CounterPunch: What Integrity Means to Pfizer
Pfizer’s $2.3 billion health care fraud settlement with the government announced this month by the US Department of Justice adds some firsts to the world’s biggest pharmaceutical company. It covers Pfizer’s kickbacks to health care providers and false claims submitted to government health care programs, also known as our tax dollars, in violation of the Food, Drug and Cosmetic Act. Forty-three states will share in the “give backs.”